Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Taro Pharmaceutical Industries, Ltd. (NYSE: TARO).

Full DD Report for TARO

You must become a subscriber to view this report.


Recent News from (NYSE: TARO)

Taro Pharmaceutical misses by $0.62, misses on revenue
Taro Pharmaceutical (NYSE: TARO ): Q1 EPS of $1.71 misses by $0.62 . More news on: Taro Pharmaceutical Industries Ltd, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 09 2018 17:52
Taro Provides Results for Quarter Ended June 2018
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2018. Quarter ended June 30, 2018 Highlights - compared to June 30, 2017 Net sales of $154.6 million, de...
Source: Business Wire
Date: August, 09 2018 17:49
Taro to Announce First Quarter Results on August 9, 2018
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2018, after the close of market on Thursday, August 9, 2018. The release will be accessible on Taro’s website at www.taro.com . Abou...
Source: Business Wire
Date: August, 02 2018 13:44

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-1088.2289.4690.0086.7152,412
2018-12-07104.50101.11105.2598.2191,770
2018-12-06105.13104.69106.90104.4060,710
2018-12-04104.36106.01106.1425104.2066,248
2018-12-03108.00104.41109.03103.9354,108

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-106601,90034.7368Cover
2018-12-071,4631,75883.2196Short
2018-12-061,3421,75076.6857Short
2018-12-047901,07673.4201Short
2018-12-0312144127.4376Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on TARO.


About Taro Pharmaceutical Industries, Ltd. (NYSE: TARO)

Logo for Taro Pharmaceutical Industries, Ltd. (NYSE: TARO)

Pharmaceutical/ Manufacturing

 

Contact Information

 

 

Current Management

  • Tal Levitt / SVP, Bus. Affairs
  • Samuel Rubinstein / Senior VP, Gen. Manager
  • Ron Kolker / Senior VP, CFO
  • Roanne Kulakoff / IR
  • Barrie Levitt / Chairman
  • Dov Pekelman /

Current Share Structure

  • Market Cap: $4,656,183,110 - 05/29/2018
  • Authorized: 200,000,000 - 12/31/2007
  • Issue and Outstanding: 40,513,209 - 03/31/2017

 


Recent Filings from (NYSE: TARO)

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: August, 10 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: August, 02 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: June, 22 2018
Annual and transition report of foreign private issuers under sections 13 or 15(d)
Filing Type: 20-FFiling Source: edgar
Filing Date: June, 21 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 18 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 11 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: February, 07 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: January, 31 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: January, 03 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: November, 24 2017

 

 


Daily Technical Chart for (NYSE: TARO)

Daily Technical Chart for (NYSE: TARO)


Stay tuned for daily updates and more on (NYSE: TARO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: TARO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in TARO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of TARO and does not buy, sell, or trade any shares of TARO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/